Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

SKUL Insider Trading

SKUL | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at SKUL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2015-12-10 02:28 2015-12-08 ALDEN RICK Director SELL $4.15 25,000 $103,750 858,597 -2.8%
2015-12-05 00:54 2015-12-03 PTARMAGIN, LLC 10% owner SELL $4.25 37,500 $159,375 4,577,386 -0.8%
2015-12-01 03:37 2015-11-25 PTARMAGIN, LLC 10% owner SELL $4.22 152,000 $641,881 4,614,886 -3.2%
2015-11-21 00:32 2015-11-19 PTARMAGIN, LLC 10% owner SELL $4.26 37,500 $159,750 4,766,886 -0.8%
2015-11-14 00:29 2015-11-12 PTARMAGIN, LLC 10% owner SELL $4.34 37,500 $162,750 4,804,386 -0.8%
2015-11-13 01:44 2015-11-12 Darling S Hoby Director, Officer - PRESIDENT AND CEO BUY $4.34 5,000 $21,700 111,387 +4.7%
2015-11-13 00:12 2015-11-10 GROSSO PATRICK D Officer - CHIEF LEGAL OFFICER BUY $4.68 3,230 $15,116 23,231 +16.1%
2015-11-11 02:47 2015-11-10 ALDEN RICK Director SELL $4.62 25,000 $115,500 883,597 -2.8%
2015-11-10 00:04 2015-11-05 PTARMAGIN, LLC 10% owner SELL $6.14 37,500 $230,250 4,841,886 -0.8%
2015-10-30 02:14 2015-10-29 PTARMAGIN, LLC 10% owner SELL $5.63 37,500 $211,125 4,879,386 -0.8%
2015-10-26 23:42 2015-10-22 PTARMAGIN, LLC 10% owner SELL $5.67 37,500 $212,625 4,916,886 -0.8%
2015-10-16 00:45 2015-10-15 PTARMAGIN, LLC 10% owner SELL $5.63 37,500 $211,125 4,954,386 -0.8%
2015-10-16 00:01 2015-10-13 ALDEN RICK Director SELL $5.73 25,000 $143,250 908,597 -2.7%
2015-10-10 00:25 2015-10-08 PTARMAGIN, LLC 10% owner SELL $5.84 37,500 $219,000 4,991,886 -0.7%
2015-10-02 23:03 2015-10-01 PTARMAGIN, LLC 10% owner SELL $5.55 37,500 $208,125 5,029,386 -0.7%
2015-09-28 14:10 2015-09-24 PTARMAGIN, LLC 10% owner SELL $6.19 37,500 $232,125 5,066,886 -0.7%
2015-09-19 01:15 2015-09-17 PTARMAGIN, LLC 10% owner SELL $6.46 37,500 $242,250 5,104,386 -0.7%
2015-09-15 00:05 2015-09-10 PTARMAGIN, LLC 10% owner SELL $6.59 37,500 $247,125 5,141,886 -0.7%
2015-09-11 00:52 2015-09-08 ALDEN RICK Director SELL $6.79 25,000 $169,750 933,597 -2.6%
2015-05-12 00:52 2015-05-11 O'NEILL HEIDI Director BUY $8.28 5,000 $41,393 31,434 +18.9%
2015-05-11 23:41 2015-05-08 Darling S Hoby Director, Officer - PRESIDENT AND CEO BUY $8.17 12,000 $98,032 106,387 +12.7%
2014-11-20 01:32 2014-11-18 Darling S Hoby Director, Officer - PRESIDENT AND CEO BUY $8.13 3,000 $24,386 100,669 +3.1%
2014-11-20 01:30 2014-11-18 Hodell Jason Officer - CHIEF FINANCIAL OFFICER BUY $8.12 4,300 $34,916 61,469 +7.5%
2014-08-12 03:15 2014-08-08 Hodell Jason Officer - CHIEF FINANCIAL OFFICER BUY $7.29 5,500 $40,095 57,169 +10.6%
2014-03-19 02:25 2014-03-17 WARNOCK GREG Director SELL $9.53 42,850 $408,365 45,354 -48.6%
2014-03-15 01:22 2014-03-12 PTARMAGIN, LLC 10% owner SELL $9.17 1,500,000 $13,757,250 5,179,386 -22.5%
2013-08-09 23:22 2013-08-07 Darling S Hoby Director, Officer - PRESIDENT AND CEO BUY $5.10 10,000 $51,000 330,679 +3.1%
2013-05-14 23:58 2013-05-10 Darling S Hoby Director, Officer - PRESIDENT AND CEO BUY $5.41 10,000 $54,075 320,679 +3.2%
2013-03-19 00:09 2013-03-14 WESCOAT KYLE B Officer - SENIOR VP AND CFO BUY $5.25 15,000 $78,750 36,177 +70.8%
2013-01-31 00:43 2013-01-28 ANDRUS JEREMY Director, Officer - PRESIDENT AND CEO SELL $6.78 20,000 $135,688 1,629,438 -1.2%
2012-12-29 01:02 2012-12-26 ANDRUS JEREMY Director, Officer - PRESIDENT AND CEO SELL $8.15 20,000 $163,080 1,644,438 -1.2%
2012-11-29 00:50 2012-11-27 Collier Douglas P Director BUY $8.25 2,000 $16,500 8,319 +31.7%
2012-11-29 00:48 2012-11-26 ANDRUS JEREMY Director, Officer - PRESIDENT AND CEO SELL $7.98 20,000 $159,500 1,659,438 -1.2%
2012-11-02 23:43 2012-10-31 PTARMAGIN, LLC 10% owner SELL $12.26 26,000 $318,773 6,683,050 -0.4%
2012-10-25 23:55 2012-10-23 PTARMAGIN, LLC 10% owner SELL $12.01 26,000 $312,273 6,709,050 -0.4%
2012-10-23 00:04 2012-10-18 ALDEN RICK Director SELL $12.37 16,000 $197,920 937,526 -1.7%
2012-10-18 23:55 2012-10-16 PTARMAGIN, LLC 10% owner SELL $12.62 26,000 $328,149 6,735,050 -0.4%
2012-10-03 23:37 2012-10-01 ANDRUS JEREMY Director, Officer, 10% owner - PRESIDENT AND CEO SELL $13.97 40,896 $571,117 1,674,438 -2.4%
2012-08-28 03:11 2012-08-23 KEARL JEFF Director SELL $14.94 154,950 $2,314,674 18,207 -89.5%
2012-08-09 23:18 2012-08-07 WARNOCK GREG Director SELL $15.59 229,736 $3,581,538 0 -100.0%
2012-05-14 20:17 2012-05-10 ROSS RONALD Officer - PRINC. ACCOUNTING OFFICER BUY $13.82 18,000 $248,679 39,000 +85.7%
2012-03-12 15:43 2012-03-08 ALDEN RICK Director BUY $14.40 17,400 $250,577 947,207 +1.9%
2011-09-16 20:04 2011-09-15 EDWARDS MITCH Officer - CFO AND GENERAL COUNSEL BUY $13.33 10,000 $133,316 10,000 +100.0%
2011-08-25 03:15 2011-07-25 KEARL JEFF Director, 10% owner OPT+S $18.60 67,180 $1,249,548 0 0.0%
2011-07-28 02:46 2011-07-25 WARNOCK GREG Director SELL $18.60 474,626 $8,828,044 714,961 -39.9%
2011-07-28 02:45 2011-07-25 SARGENTE RICHARD Officer - VP, N. AMERICA SALES OPT+S $18.60 7,526 $139,984 0 0.0%
2011-07-28 02:44 2011-07-25 PTARMIGAN, LLC 10% owner SELL $18.60 968,582 $18,015,625 6,766,950 -12.5%
2011-07-28 02:44 2011-07-25 Olivet D Scott Director BUY $20.00 7,500 $150,000 7,500 +100.0%
2011-07-28 02:43 2011-07-25 MIYASAKI CLARKE Officer - VP, GLOBAL BUS DVLPMNT BUY $20.00 250 $5,000 250 +100.0%
2011-07-28 02:43 2011-07-25 KEARL JEFF Director, 10% owner OPT+S $18.60 67,180 $1,249,548 790 0.0%
SHOW ENTRIES
51-100 OF 103

How to Interpret $SKUL Trades

Not every insider transaction in SKUL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SKUL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for SKUL

Insider activity data for SKUL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SKUL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.